Head and Neck Squamous-Cell Cancer and its Association with Polymorphic Enzymes of Xenobiotic Metabolism and Repair-Reference-Cited by-同舟云学术

Head and Neck Squamous-Cell Cancer and its Association with Polymorphic Enzymes of Xenobiotic Metabolism and Repair

Published:2008-06-03 Issue:13-14 Volume:71 Page:887-897
ISSN:1528-7394
Container-title:Journal of Toxicology and Environmental Health, Part A
language:en
Short-container-title:Journal of Toxicology and Environmental Health, Part A

Author:

Harth Volker,Schäfer Martin,Abel Josef,Maintz Laura,Neuhaus Thomas,Besuden Mette,Primke Robert,Wilkesmann Anja,Thier Ricarda,Vetter Hans,Ko Yon-Dschun,Brüning Thomas,Bolt Hermann M.,Ickstadt Katja

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://www.tandfonline.com/doi/pdf/10.1080/15287390801988160

Reference45 articles.

1. Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[a]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[a]pyrene

2. Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism

3. Association of polymorphisms in thecyclin D1 andXPD genes and susceptibility to cancers of the upper aero-digestive tract

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutathione S-transferase theta 1 (GSTT1) deletion polymorphism and susceptibility to head and neck carcinoma: a systematic review with five analyses;BMC Cancer;2024-07-22

2. Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers;Journal of Neuro-Oncology;2023-06

3. THE ROLE OF CYP1B1 IN ORAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS;WORLD CANCER RES J;2023

4. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta‐analysis;Cancer Reports;2022-12-27

5. Investigation of CYP1B1*3 and CYP1B1*4 polymorphisms in a Turkish population;Health Sciences Quarterly;2022-07-28